The Market Reports

Synopsis
The global market for Orally Disintegrating Tablet was estimated to be worth US$ 17300 million in 2024 and is forecast to a readjusted size of US$ 37140 million by 2031 with a CAGR of 11.7% during the forecast period 2025-2031.
An orally disintegrating tablet or orally dissolving tablet (ODT) is a drug dosage form available for a limited range of over-the-counter (OTC) and prescription medications. ODTs differ from traditional tablets in that they are designed to be dissolved on the tongue rather than swallowed whole. The ODT serves as an alternative dosage form for patients who experience dysphagia (difficulty in swallowing) or for where compliance is a known issue and therefore an easier dosage form to take ensures that medication is taken.
Market Drivers:
The global Orally Disintegrating Tablet (ODT) market is primarily driven by increasing demand for convenient and patient-friendly drug delivery systems. As the global aging population grows and more patients experience difficulty swallowing traditional tablets and capsules, ODTs provide an effective alternative. The pediatric segment also fuels growth due to the ease of administration and improved compliance. Additionally, advancements in formulation technologies, such as the use of superdisintegrants and taste-masking agents, have enhanced the efficacy and palatability of ODTs, encouraging pharmaceutical companies to develop more drugs in this format.
Market Challenges:
Despite strong demand, the ODT market faces several challenges. One major barrier is the complexity and higher cost of manufacturing ODTs compared to conventional tablets, especially in achieving quick disintegration and taste masking without compromising drug stability. Regulatory hurdles can also slow product approvals due to stringent quality standards. Moreover, not all active pharmaceutical ingredients (APIs) are suitable for ODT formulation due to factors like dose size, bitterness, or poor solubility, which limits the range of drugs that can be adapted into this format.
Market Trends:
The ODT market is witnessing a trend toward expansion into high-value therapeutic areas such as central nervous system disorders, cardiovascular diseases, and pain management. Additionally, there is increasing interest in combining ODTs with rapid-onset APIs for emergency-use treatments like migraines and seizures. Technological innovations in 3D printing and polymer-based film layering are also contributing to more customizable and faster-dissolving ODTs. As more generic and branded drug manufacturers recognize the commercial potential of this dosage form, the market is expected to grow steadily in both developed and emerging economies.
This report aims to provide a comprehensive presentation of the global market for Orally Disintegrating Tablet, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Orally Disintegrating Tablet by region & country, by Type, and by Application.
This report provides a comprehensive assessment of recent tariff adjustments and international strategic countermeasures on Orally Disintegrating Tablet cross-border industrial footprints, capital allocation patterns, regional economic interdependencies, and supply chain reconfigurations.
The Orally Disintegrating Tablet market size, estimations, and forecasts are provided in terms of sales volume (M Units) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Orally Disintegrating Tablet.
Market Segmentation
By Company
Teva
Merck
Viatris
Pfizer
Johnson and Johnson
GSK
Otsuka
Eli Lilly and Company
AstraZeneca
Bristol-Myers Squibb
Conquer
Eisai
Cipla
Zydus Lifesciences
Segment by Type
Anti-Psychotics Drug
Anti-Epileptics Drug
Others
Segment by Application
CNS Diseases
Gastrointestinal Diseases
CVS Diseases
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia-Pacific
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Orally Disintegrating Tablet manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Orally Disintegrating Tablet in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Orally Disintegrating Tablet in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Index